Antibiotic Stewardship in AECOPD Through CRP-Guided Management

NANot yet recruitingINTERVENTIONAL
Enrollment

1,184

Participants

Timeline

Start Date

September 1, 2022

Primary Completion Date

August 31, 2025

Study Completion Date

August 31, 2026

Conditions
Acute Exacerbation of COPDLung DiseasesLung Diseases, ObstructivePulmonary Disease, Chronic ObstructiveRespiratory Tract Disease
Interventions
PROCEDURE

The intervention (CRP-guided) group

"The attending doctor will use the CRP level to inform their decision to continue antibiotics around 3 hours from blood taking. These doctors will be provided pre-study training on CRP interpretation.~Every day from randomization, serum CRP testing will be encouraged to take. Once CRP has declined to \<5mg/dL and the patient has remained afebrile for past 48 hours, antibiotic treatment will be reviewed for discontinuation. Otherwise, antibiotic treatment will be continued. A switch on the administration route, or a change of antibiotics due to adverse effect, allergy, or suggestion from culture result, is permitted according to in-patient physician's decisions. CRP will continue to be monitored daily upon discharge from that hospital (up to 28 days)."

Trial Locations (1)

Unknown

Queen Mary Hospital, Hong Kong

All Listed Sponsors
collaborator

Food and Health Bureau, Hong Kong

OTHER_GOV

lead

The University of Hong Kong

OTHER

NCT05286918 - Antibiotic Stewardship in AECOPD Through CRP-Guided Management | Biotech Hunter | Biotech Hunter